UBS Group’s Vascular Solutions VASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-4,239
| Closed | -$237K | – | 8374 |
|
|
2016
Q4 | $237K | Buy |
4,239
+1,401
| +49% | +$71.4K | ﹤0.01% | 4676 |
|
|
2016
Q3 | $137K | Sell |
2,838
-993
| -26% | -$46.3K | ﹤0.01% | 4796 |
|
|
2016
Q2 | $159K | Sell |
3,831
-3,484
| -48% | -$130K | ﹤0.01% | 4700 |
|
|
2016
Q1 | $239K | Sell |
7,315
-2,109
| -22% | -$60.8K | ﹤0.01% | 4367 |
|
|
2015
Q4 | $324K | Sell |
9,424
-697
| -7% | -$23.6K | ﹤0.01% | 4296 |
|
|
2015
Q3 | $328K | Buy |
10,121
+1,243
| +14% | +$44.5K | ﹤0.01% | 4238 |
|
|
2015
Q2 | $308K | Sell |
8,878
-1,866
| -17% | -$60.9K | ﹤0.01% | 4498 |
|
|
2015
Q1 | $326K | Sell |
10,744
-4,707
| -30% | -$135K | ﹤0.01% | 4486 |
|
|
2014
Q4 | $420K | Buy |
15,451
+2,909
| +23% | +$79K | ﹤0.01% | 4349 |
|
|
2014
Q3 | $310K | Buy |
12,542
+741
| +6% | +$17.6K | ﹤0.01% | 4742 |
|
|
2014
Q2 | $262K | Buy |
11,801
+1,037
| +10% | +$22.7K | ﹤0.01% | 4876 |
|
|
2014
Q1 | $282K | Buy |
10,764
+7,654
| +246% | +$191K | ﹤0.01% | 4823 |
|
|
2013
Q4 | $72K | Buy |
3,110
+1,180
| +61% | +$23.1K | ﹤0.01% | 6480 |
|
|
2013
Q3 | $32K | Sell |
1,930
-570
| -23% | -$9.23K | ﹤0.01% | 7480 |
|
|
2013
Q2 | $37K | Hold |
2,500
| – | – | ﹤0.01% | 7143 |
|
Other funds holding VASC
UBS Group's VASC Position: Q1 2017 in Review
UBS Group sold out of Vascular Solutions (VASC) in Q1 2017, closing a stake of 4,239 shares — an estimated $237K sold.
UBS Group first reported a position in VASC in Q2 2013 and held it in 15 quarters. The position peaked at $420K in Q4 2014. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.
- UBS Group reported no remaining Vascular Solutions position as of Q1 2017 after selling out during the quarter.
- UBS Group sold 4,239 Vascular Solutions shares in Q1 2017, an estimated $237K.
- UBS Group first reported a position in Vascular Solutions in Q2 2013 and held it in 15 quarters.
- UBS Group's Vascular Solutions position peaked at $420K in Q4 2014.
- 1 fund tracked by Wall St. Rank held Vascular Solutions as of Q1 2017.
Based on UBS Group's 13F filing for Q1 2017, filed 12 May 2017.